Trevor Anthony Mill
Corporate Officer/Principal presso COMPASS PATHWAYS PLC
Profilo
Trevor Anthony Mill is currently a Director at Biogen Idec Ltd., Convergence Pharmaceuticals Ltd., Silver Acquisition Co. Ltd., Convergence Pharmaceuticals Holdings Ltd., Old Convergence Pharmaceuticals Ltd., and the Chief Development Officer at Compass Pathways Plc.
He was previously a Director at Nightstar Therapeutics Ltd., Vice President-Regulatory Affairs at Pfizer Inc., Senior Manager-Regulatory Affairs & Project at Johnson & Johnson, Inc., and SVP, Head-Global Safety & Regulatory Sciences at Biogen, Inc.
Posizioni attive di Trevor Anthony Mill
Società | Posizione | Inizio |
---|---|---|
COMPASS PATHWAYS PLC | Corporate Officer/Principal | 01/06/2020 |
Biogen Idec Ltd.
Biogen Idec Ltd. BiotechnologyHealth Technology Biogen Idec Ltd. develops therapies for neurodegenerative, haematologic, and autoimmune disorders. The firm develops treatment for Alzheimer’s Disease, spinal muscular atrophy, lupus, and amyotrophic lateral sclerosis (ALS), amongst others. The company was founded on 2003 and is headquartered in Maidenhead, the United Kingdom. | Director/Board Member | 16/04/2012 |
Convergence Pharmaceuticals Holdings Ltd.
Convergence Pharmaceuticals Holdings Ltd. Financial ConglomeratesFinance Part of Biogen, Inc., Convergence Pharmaceuticals Holdings Ltd. functions as an investment holding British company. The private company is based in Maidenhead, UK. | Director/Board Member | - |
Silver Acquisition Co. Ltd.
Silver Acquisition Co. Ltd. BiotechnologyHealth Technology Founded in 2014, Silver Acquisition Co. Ltd. is a biotechnology research and British experimental development company. Part of Biogen, Inc., the private company is based in Maidenhead, UK. The company's focus is on developing new biotechnology products through research and experimentation. | Director/Board Member | 19/12/2014 |
Convergence Pharmaceuticals Ltd.
Convergence Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Convergence Pharmaceuticals Ltd. develops novel analgesics for the treatment of chronic pain. It provides CNV1014802, a small molecule state-dependent sodium channel blocker; and CNV1061436, a sodium channel blocker for the treatment of central nervous system disorders, including epilepsy and bipolar disorder. The company was founded by Brenda Reynolds in September 2010 and is headquartered in Cambridge, the United Kingdom. | Director/Board Member | 06/01/2015 |
Old Convergence Pharmaceuticals Ltd.
Old Convergence Pharmaceuticals Ltd. Miscellaneous Commercial ServicesCommercial Services Founded in 2010, Old Convergence Pharmaceuticals Ltd. is a subsidiary of Biogen, Inc. that develops analgesics for the treatment of chronic pain. The private company is based in Maidenhead, UK. | Director/Board Member | 11/02/2015 |
Precedenti posizioni note di Trevor Anthony Mill
Società | Posizione | Fine |
---|---|---|
BIOGEN INC. | Compliance Officer | 01/12/2016 |
NIGHTSTAR THERAPEUTICS PLC | Director/Board Member | 31/01/2020 |
PFIZER, INC. | General Counsel | 01/01/2011 |
░░░░░░░ ░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 3 |
---|---|
PFIZER, INC. | Health Technology |
BIOGEN INC. | Health Technology |
COMPASS PATHWAYS PLC | Health Technology |
Aziende private | 7 |
---|---|
Johnson & Johnson, Inc.
Johnson & Johnson, Inc. Insurance Brokers/ServicesFinance Johnson & Johnson, Inc. provides insurance brokerage services. The company was founded in 1930 and is headquartered in Mount Pleasant, SC. | Finance |
Biogen Idec Ltd.
Biogen Idec Ltd. BiotechnologyHealth Technology Biogen Idec Ltd. develops therapies for neurodegenerative, haematologic, and autoimmune disorders. The firm develops treatment for Alzheimer’s Disease, spinal muscular atrophy, lupus, and amyotrophic lateral sclerosis (ALS), amongst others. The company was founded on 2003 and is headquartered in Maidenhead, the United Kingdom. | Health Technology |
Convergence Pharmaceuticals Ltd.
Convergence Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Convergence Pharmaceuticals Ltd. develops novel analgesics for the treatment of chronic pain. It provides CNV1014802, a small molecule state-dependent sodium channel blocker; and CNV1061436, a sodium channel blocker for the treatment of central nervous system disorders, including epilepsy and bipolar disorder. The company was founded by Brenda Reynolds in September 2010 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Silver Acquisition Co. Ltd.
Silver Acquisition Co. Ltd. BiotechnologyHealth Technology Founded in 2014, Silver Acquisition Co. Ltd. is a biotechnology research and British experimental development company. Part of Biogen, Inc., the private company is based in Maidenhead, UK. The company's focus is on developing new biotechnology products through research and experimentation. | Health Technology |
Convergence Pharmaceuticals Holdings Ltd.
Convergence Pharmaceuticals Holdings Ltd. Financial ConglomeratesFinance Part of Biogen, Inc., Convergence Pharmaceuticals Holdings Ltd. functions as an investment holding British company. The private company is based in Maidenhead, UK. | Finance |
Nightstar Therapeutics Ltd.
Nightstar Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Nightstar Therapeutics Ltd. is a clinical-stage gene therapy. It engages in the development and commercialization of novel one-time treatments for patients suffering from rare inherited retinal diseases. The company was founded by Robert MacLaren, Miguel Seabra and Matthew During in 2014 and is headquartered in London, the United Kingdom. | Health Technology |
Old Convergence Pharmaceuticals Ltd.
Old Convergence Pharmaceuticals Ltd. Miscellaneous Commercial ServicesCommercial Services Founded in 2010, Old Convergence Pharmaceuticals Ltd. is a subsidiary of Biogen, Inc. that develops analgesics for the treatment of chronic pain. The private company is based in Maidenhead, UK. | Commercial Services |
- Borsa valori
- Insiders
- Trevor Anthony Mill